Clinical Trial Update: VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating VEGF levels in aqueous, vitreous, and subretinal fluid in Retinopathy of Prematurity stages IV and V has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Retinopathy of Prematurity | Phase 4 | Status: WITHDRAWN